Reducing the frequency of menses: Extended contraception, a review;Diminuer la fréquence des règles: Le point sur la contraception étendue

Gynecologie Obstetrique et Fertilite

Volumn 41, Issue 6, 2013, Pages 381-387

  This, P ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breakthrough bleeding; Continuous contraception; Extended contraception; Headache; Menorrhagia; Spotting; Withdrawal bleeding

Indexed keywords

CONTRACEPTIVE AGENT;

DYSMENORRHEA; FEMALE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; MIGRAINE; PATIENT ATTITUDE; PREMENSTRUAL SYNDROME; REVIEW; SPOTTING;

EID: 84879419397     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2013.05.003     Document Type: Article

References (58)

1. S.L. Thomas, and C. Ellertson Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet 355 2000 922 924
2. D.F. Archer Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives Contraception 74 2006 359 366
3. F. Prioux Late fertility in Europe: some comparative and historical data Rev Epidemiol Sante Publique 2 2005 3 11 [53 Spec No]
4. R. Burkman, C. Bell, and D. Serfaty The evolution of combined oral contraception: improving the risk-to-benefit ratio Contraception 84 2011 19 34
5. J. Steinauer, and A.M. Autry Extended cycle combined hormonal contraception Obstet Gynecol Clin North Am 34 2007 43 55 [viii]
6. P. Barjot, O. Graesslin, D. Cohen, P. Vaillant, P. Clerson, and M. Hoffet Pregnancies occurring during oral contraception: lessons from the GRECO study Gynecol Obstet Fertil 34 2006 120 126
7. E. Aubeny, M. Buhler, J.C. Colau, E. Vicaut, M. Zadikian, and M. Childs The Coraliance study: non-compliant behavior. Results after a 6-month follow-up of patients on oral contraceptives Eur J Contracept Reprod Health Care 9 2004 267 277
8. J.S. Gunson "More natural but less normal": reconsidering medicalisation and agency through women's accounts of menstrual suppression Soc Sci Med 71 2010 1324 1331
9. A.F. Glasier, K.B. Smith, Z.M. van der Spuy, P.C. Ho, L. Cheng, and K. Dada Amenorrhea associated with contraception-an international study on acceptability Contraception 67 2003 1 8
10. S. Mimoun, M.G. Le, M. Buhler, A. Costa, and F. Hosansky The experience of menstruation and its disorders in 603 women using contraception in 1999 Gynecol Obstet Fertil 28 2000 904 912
11. I. den Tonkelaar, and B.J. Oddens Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use Contraception 59 1999 357 362
12. W. Rutter, C. Knight, J. Vizzard, M. Mira, and S. Abraham Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill Med J Aust 149 1988 417 419
13. J. Shakespeare, E. Neve, and K. Hodder Is norethisterone a lifestyle drug? Results of database analysis BMJ 320 2000 291
14. L.C. Andrist, A. Hoyt, D. Weinstein, and C. McGibbon The need to bleed: women's attitudes and beliefs about menstrual suppression J Am Acad Nurse Pract 16 2004 31 37
15. C.E. Frederick, A. Edelman, N.E. Carlson, K.D. Rosenberg, and J.T. Jensen Extended-use oral contraceptives and medically induced amenorrhea: attitudes, knowledge and prescribing habits of physicians Contraception 84 2011 384 389
16. L.C. Andrist, R.D. Arias, D. Nucatola, A.M. Kaunitz, B.L. Musselman, and S. Reiter Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives Contraception 70 2004 359 363
17. D.L. Seval, T. Buckley, T.J. Kuehl, and P.J. Sulak Attitudes and prescribing patterns of extended-cycle oral contraceptives Contraception 84 2011 71 75
18. S.P. Shrader, and L.M. Dickerson Extended- and continuous-cycle oral contraceptives Pharmacotherapy 28 2008 1033 1040
19. J.T. Jensen, S. Parke, U. Mellinger, A. Machlitt, and I.S. Fraser Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial Obstet Gynecol 117 2011 777 787
20. S.A. Willis, T.J. Kuehl, A.M. Spiekerman, and P.J. Sulak Greater inhibition of the pituitary - ovarian axis in oral contraceptive regimens with a shortened hormone-free interval Contraception 74 2006 100 103
21. R.S. Legro, J.G. Pauli, A.R. Kunselman, J.W. Meadows, J.S. Kesner, and R.J. Zaino Effects of continuous versus cyclical oral contraception: a randomized controlled trial J Clin Endocrinol Metab 93 2008 420 429
22. A. Edelman, M.F. Gallo, M.D. Nichols, J.T. Jensen, K.F. Schulz, and D.A. Grimes Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials Hum Reprod 21 2006 573 578
23. A. Edelman, M. Gallo, J. Jensen, M. Nichols, and D. Grimes Continuous or extended cycle vs cycle use of combined hormonal contraceptives fo contraception (Review) Cochrane Library 8 2010 1 61
24. A.C. Cachrimanidou, D. Hellberg, S. Nilsson, U. Waldenstrom, S.E. Olsson, and B. Sikstrom Long-interval treatment regimen with a desogestrel-containing oral contraceptive Contraception 48 1993 205 216
25. E.M. Coutinho, E. O'Dwyer, I.C. Barbosa, Z.P. Gu, M.M. Shaaban, and M. Aboul-Oyoon Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route Contraception 51 1995 355 358
26. L. Miller, and K.M. Notter Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial Obstet Gynecol 98 2001 771 778
27. F.D. Anderson, and H. Hait A multicenter, randomized study of an extended cycle oral contraceptive Contraception 68 2003 89 96
28. M. Kwiecien, A. Edelman, M.D. Nichols, and J.T. Jensen Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial Contraception 67 2003 9 13
29. L. Miller, and J.P. Hughes Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial Obstet Gynecol 101 2003 653 661
30. L. Miller, C.H. Verhoeven, and J. Hout Extended regimens of the contraceptive vaginal ring: a randomized trial Obstet Gynecol 106 2005 473 482
31. F.H. Stewart, A.M. Kaunitz, K.D. Laguardia, D.L. Karvois, A.C. Fisher, and A.J. Friedman Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial Obstet Gynecol 105 2005 1389 1396
32. P. Vercellini, G. Frontino, O. De Giorgi, G. Pietropaolo, R. Pasin, and P.G. Crosignani Continuous use of an oral contraceptive for endometriosis- associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen Fertil Steril 80 2003 560 563
33. A. Calhoun, S. Ford, and A. Pruitt The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series Headache 52 2012 1246 1253
34. P.J. Sulak, T.J. Kuehl, A. Coffee, and S. Willis Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen Am J Obstet Gynecol 195 2006 935 941
35. J.T. Jensen, S.G. Garie, D. Trummer, and J. Elliesen Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study Contraception 86 2012 110 118
36. M.B. Bracken Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies Obstet Gynecol 76 1990 552 557
37. P.C. Hannaford, S. Selvaraj, A.M. Elliott, V. Angus, L. Iversen, and A.J. Lee Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study BMJ 335 2007 651
38. F.D. Anderson, H. Hait, J. Hsiu, A.L. Thompson-Graves, W.H. Wilborn, and R.F. Williams Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen Contraception 71 2005 55 59
39. F.D. Anderson, R. Feldman, and K.Z. Reape Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo Contraception 77 2008 91 96
40. J.M. Foidart, P.J. Sulak, I. Schellschmidt, and D. Zimmermann The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days Contraception 73 2006 34 40
41. D. Serfaty, and C. D'Arcangues Contraception du futur Elsevier Masson Contraception 2011 Elsevier Masson Paris 517 519
42. I. Wiegratz, S. Stahlberg, T. Manthey, N. Sanger, K. Mittmann, and E. Palombo-Kinne Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use Contraception 81 2010 57 61
43. M.W. van den Heuvel, A.J. van Bragt, A.K. Alnabawy, and M.C. Kaptein Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 2005 168 174
44. N.J. Alexander, E. Baker, M. Kaptein, U. Karck, L. Miller, and E. Zampaglione Why consider vaginal drug administration? Fertil Steril 82 2004 1 12
45. C.A. Guazzelli, F.A. Barreiros, M.R. Torloni, and M. Barbieri Effects of extended regimens of the contraceptive vaginal ring on carbohydrate metabolism Contraception 85 2012 253 256
46. C.A. Guazzelli, F.A. Barreiros, R. Barbosa, M.R. Torloni, and M. Barbieri Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism Contraception 85 2012 389 393
47. J. Guillebaud Reducing withdrawal bleeds Lancet 355 2000 2168 2169
48. C.E. DiLiberti, C.M. O'Leary, C.H. Hendy, D.H. Waters, and M.B. Margolis Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen Contraception 83 2011 55 61
49. C.A. Guazzelli, F.T. de Queiroz, M. Barbieri, M.R. Torloni, and F.F. de Araujo Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate Contraception 82 2010 256 259
50. M. Laban, M. Abd Alhamid, E.A. Ibrahim, A. Elyan, and A. Ibrahim Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt Eur J Contracept Reprod Health Care 17 2012 451 457
51. P. Collinet, M. Nayama, and M. Cosson Acceptability of intrauterine levonorgestrel delivery system (Mirena 52 mg) after estrogen-progesterone oral contraception: results of a prospective multicentric study of 211 patients aged 25-35 years J Gynecol Obstet Biol Reprod (Paris) 35 2006 778 784
52. M. Ronnerdag, and V. Odlind Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use Acta Obstet Gynecol Scand 78 1999 716 721
53. P. Inki Long-term use of the levonorgestrel-releasing intrauterine system Contraception 75 2007 S161 S166
54. A. van Hylckama Vlieg, F.M. Helmerhorst, and F.R. Rosendaal The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device Arterioscler Thromb Vasc Biol 30 2010 2297 2300
55. A.M. Kaunitz Long-acting injectable contraception with depot medroxyprogesterone acetate Am J Obstet Gynecol 170 1994 1543 1549
56. S. Ray, and V.B. Sovani A postmarketing observational study assessing acceptability and reliability of desogestrel only contrapceptive pill (Cerazette) in Indian women J Indian Med Assoc 104 2006 653 656
57. P. Madelenat, and M. Koskas Update on the progestin-only contraception J Gynecol Obstet Biol Reprod (Paris) 37 2008 637 660
58. P. This, and P. Panel Shared medical decision making in gynaecology Gynecol Obstet Fertil 38 2010 126 134